However, Mounjaro has been proven to be more effective for weight loss, resulting in an average 22.5% weight loss over 72 weeks at the highest maintenance dose compared to 21% using Wegovy at the highest maintenance dose over 72 weeks
Rise after a few mins
MEDICAL WEIGHT LOSS Semaglutide Covered By Some Insurances
it requires a partnership
The FDA has not approved any GLP-1 receptor agonist solely for weight loss in teenagers as of 2024, though research initiatives are underway to evaluate safety in younger populations
Supplier and product pages should be evaluated for third-party testing, batch-specific certificates of analysis, named laboratory verification, transparent pricing, realistic delivery expectations, payment security, refund policies, support quality, and consistent research-use-only labeling